See also this year's filing and all EDGAR filings for this company.
PDF Report 0000899866_2018_ALEXION_PHARMACEUTICALS_INC.pdf
Logs
warning | Missing logo | subcommand.report | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0000899866')"} |
info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000899866, ALEXION PHARMACEUTICALS INC.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 2,953,900,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 8,991,800,000 |
2 | PropertyPlantAndEquipmentNet | 1,325,400,000 |
3 | remainder_Assets | 312,200,000 |
4 | LiabilitiesCurrent | 952,500,000 |
5 | LiabilitiesNoncurrent | 2,860,900,000 |
6 | remainder_Liabilities | 876,800,000 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 1,094,400,000 |
9 | ResearchAndDevelopmentExpense | 878,400,000 |
10 | remainder_Expenses | 1,153,800,000 |
11 | remainder_Revenues | 3,551,100,000 |
12 | remainder_NetIncome | 18,800,000 |
13 | remainder_ComprehensiveNetIncome | -94,900,000 |
yvar | yval | |
---|---|---|
0 | Assets | 13,583,300,000 |
1 | Liabilities | 4,690,200,000 |
2 | Expenses | 3,126,600,000 |
3 | Revenues | 3,551,100,000 |
4 | StockholdersEquity | 8,893,100,000 |
5 | NetIncome | 443,300,000 |
6 | ComprehensiveNetIncome | 395,850,000 |
7 | BaseVar | 12,532,450,000 |
8 | EconomicCapitalRatio | 1.72 |